Is muscarinic receptor agonist effective and tolerant for schizophrenia?
Abstract Background Several randomized clinical trials (RCTs) have recently examined the efficacy and tolerability of muscarinic receptor agonists in schizophrenia. However, whether therapeutics targeting muscarinic receptors improve symptom management and reduce side effects remains systemically un...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2025-04-01
|
| Ráidu: | BMC Psychiatry |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12888-025-06662-1 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|